DBV712 clinical trials

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

This study is looking at a skin patch treatment (DBV712) for peanut allergy in children aged 4 to 7. It aims to see if the patch can make children less sensitive to peanuts and how safe it is over time.